Boyce Brenda A Brady, Yee Barbara Homer
Assessment and Remediation, Ready-point Nursing, Pearson Education, 75 Arlington St, Suite 6W056, Boston, MA 02116, USA.
Crit Care Nurse. 2012 Aug;32(4):27-34. doi: 10.4037/ccn2012139.
Nurses noted that the rate of phlebitis was high when intravenous amiodarone was infused via a peripheral site. Hospital policy recommends a central vascular catheter, but this method is often not feasible because the drug is administered in emergent situations for short periods.
To determine the rate and severity of phlebitis in patients given peripherally infused amiodarone.
The literature, policy, and procedures for administration of amiodarone were reviewed; the pharmacy was consulted; and a data collection tool was developed. The tool was pilot tested and revised, and face validation was established. Data were collected during a 6-month period. A convenience sample was used.
The study included a total of 12 patients. Each new infusion of intravenous amiodarone was considered a separate occurrence, for a total of 24 infusions. Various grades of phlebitis developed in 8 patients (67%). Phlebitis developed at 12 of the 24 infusion sites (50%).
Patients receiving peripherally infused amiodarone are at high risk for phlebitis. This complication may lead to infection, additional medical intervention, delay in treatment, and prolonged hospitalization.
护士们注意到，通过外周静脉输注胺碘酮时静脉炎发生率很高。医院政策推荐使用中心静脉导管，但这种方法通常不可行，因为该药物常用于紧急情况下的短期给药。
确定外周静脉输注胺碘酮患者的静脉炎发生率及严重程度。
查阅了胺碘酮给药的文献、政策和程序；咨询了药房；并开发了一种数据收集工具。该工具进行了预试验和修订，并进行了表面效度验证。在6个月期间收集数据。采用便利抽样。
该研究共纳入12例患者。每次新的静脉输注胺碘酮都被视为一次单独的事件，共计24次输注。8例患者（67%）发生了不同程度的静脉炎。24个输注部位中有12个发生了静脉炎（50%）。
接受外周静脉输注胺碘酮的患者发生静脉炎的风险很高。这种并发症可能导致感染、额外的医疗干预、治疗延迟和住院时间延长。
